PlainRecalls
FDA Drug Low Class III Completed

Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57

Reported: September 13, 2023 Initiated: July 18, 2023 #D-1145-2023

Product Description

Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57

Reason for Recall

Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.

Details

Recalling Firm
Ascend Laboratories, LLC
Units Affected
99,516 sachets
Distribution
The recall product was distributed nationwide.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57. Recalled by Ascend Laboratories, LLC. Units affected: 99,516 sachets.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 13, 2023. Severity: Low. Recall number: D-1145-2023.